These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 26672363)

  • 21. The future of iPS cells in advancing regenerative medicine.
    Liu P; Li KE; Xu S
    Genet Res (Camb); 2016 Feb; 98():e4. PubMed ID: 26864234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery.
    Murata M; Tohyama S; Fukuda K
    Pharmacol Ther; 2010 May; 126(2):109-18. PubMed ID: 20156482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem cells and regenerative medicine in domestic and companion animals: a multispecies perspective.
    Gonçalves NN; Ambrósio CE; Piedrahita JA
    Reprod Domest Anim; 2014 Oct; 49 Suppl 4():2-10. PubMed ID: 25277427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disease-in-a-dish: the contribution of patient-specific induced pluripotent stem cell technology to regenerative rehabilitation.
    Mack DL; Guan X; Wagoner A; Walker SJ; Childers MK
    Am J Phys Med Rehabil; 2014 Nov; 93(11 Suppl 3):S155-68. PubMed ID: 25122102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dedifferentiation, transdifferentiation, and reprogramming: future directions in regenerative medicine.
    Eguizabal C; Montserrat N; Veiga A; Izpisua Belmonte JC
    Semin Reprod Med; 2013 Jan; 31(1):82-94. PubMed ID: 23329641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pluripotent stem cells: the last 10 years.
    Kimbrel EA; Lanza R
    Regen Med; 2016 Dec; 11(8):831-847. PubMed ID: 27908220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spermatogonial stem cells, in vivo transdifferentiation and human regenerative medicine.
    Simon L; Hess RA; Cooke PS
    Expert Opin Biol Ther; 2010 Apr; 10(4):519-30. PubMed ID: 20146635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Probe as Surface Glycan Marker of Pluripotent Stem Cells: Research Outcomes and Application to Regenerative Medicine.
    Hirabayashi J; Tateno H; Onuma Y; Ito Y
    Adv Healthc Mater; 2015 Nov; 4(16):2520-9. PubMed ID: 25872477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem cells in drug discovery, tissue engineering, and regenerative medicine: emerging opportunities and challenges.
    Nirmalanandhan VS; Sittampalam GS
    J Biomol Screen; 2009 Aug; 14(7):755-68. PubMed ID: 19675315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human stem cell research and regenerative medicine--present and future.
    Volarevic V; Ljujic B; Stojkovic P; Lukic A; Arsenijevic N; Stojkovic M
    Br Med Bull; 2011; 99():155-68. PubMed ID: 21669982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Stem cells: scientific progress and commercial tactics].
    Nau JY
    Rev Med Suisse; 2013 Oct; 9(400):1794-5. PubMed ID: 24187755
    [No Abstract]   [Full Text] [Related]  

  • 32. Toward transgene-free induced pluripotent stem cells: lessons from transdifferentiation studies.
    Chua SJ; Casper RF; Rogers IM
    Cell Reprogram; 2011 Aug; 13(4):273-80. PubMed ID: 21599518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Regenerative medicine: history and perspectives].
    Okabayashi K; Asashima M
    Nihon Rinsho; 2008 May; 66(5):825-30. PubMed ID: 18464498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethics of research on stem cells and regenerative medicine: ethical guidelines in the Islamic Republic of Iran.
    Afshar L; Aghayan HR; Sadighi J; Arjmand B; Hashemi SM; Basiri M; Samani RO; Ashtiani MK; Azin SA; Hajizadeh-Saffar E; Gooshki ES; Hamidieh AA; Rezania Moallem MR; Azin SM; Shariatinasab S; Soleymani-Goloujeh M; Baharvand H
    Stem Cell Res Ther; 2020 Sep; 11(1):396. PubMed ID: 32928295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current applications of human pluripotent stem cells: possibilities and challenges.
    Ho PJ; Yen ML; Yet SF; Yen BL
    Cell Transplant; 2012; 21(5):801-14. PubMed ID: 22449556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging trends and new developments in regenerative medicine: a scientometric update (2000 - 2014).
    Chen C; Dubin R; Kim MC
    Expert Opin Biol Ther; 2014 Sep; 14(9):1295-317. PubMed ID: 25077605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of induced pluripotent stem cells in research and therapy of primary immunodeficiencies.
    Weinacht KG; Brauer PM; Felgentreff K; Devine A; Gennery AR; Giliani S; Al-Herz W; Schambach A; Zúñiga-Pflücker JC; Notarangelo LD
    Curr Opin Immunol; 2012 Oct; 24(5):617-24. PubMed ID: 22841347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human Pluripotent Stem Cell Mechanobiology: Manipulating the Biophysical Microenvironment for Regenerative Medicine and Tissue Engineering Applications.
    Ireland RG; Simmons CA
    Stem Cells; 2015 Nov; 33(11):3187-96. PubMed ID: 26189759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. iPS cells--alternative pluripotent cells to embryo stem cells.
    Pei X
    Sci China Life Sci; 2010 Jan; 53(1):154-156. PubMed ID: 20596969
    [No Abstract]   [Full Text] [Related]  

  • 40. Concise review: alchemy of biology: generating desired cell types from abundant and accessible cells.
    Pournasr B; Khaloughi K; Salekdeh GH; Totonchi M; Shahbazi E; Baharvand H
    Stem Cells; 2011 Dec; 29(12):1933-41. PubMed ID: 21997905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.